---
$id: https://graph.org.ai/products/commodity/51302319
$type: Product
source: UNSPSC
code: "51302319"
title: "Lanoconazole"
class: "51302300"
classTitle: "Antifungal imidazoles"
family: "51300000"
familyTitle: "Antifungal drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lanoconazole

**UNSPSC Code**: 51302319
**Class**: [Antifungal imidazoles](Antifungal imidazoles.mdx)
**Family**: [Antifungal drugs](../Antifungal drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antifungal agent with the molecular formula C14H10ClN3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4E7858311F, chemically known as 1h-imidazole-1-acetonitrile, alpha-(4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene)-, (e)-(+-)- but generally known as lanoconazole, which bears US NIH Compound Identifier 3002820. European Medicines Agency schedules Lanoconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08398MIG. The term LANOCONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). LANOCONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lanoconazole under HS 29349990 and SITC 51579. As of Q4 2014, LANOCONAZOLE remains the US FDA Preferred Term for this commodity. Lanoconazole bears US NLM identifiers UMLS ID C0125333 and NCI Concept Code C81504. SMILES: CLC1C(C2S/C(=C(/N3CCNC3)C#N)SC2)CCCC1.

